DMD Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DMD Therapeutics Inc. - overview
Established
2015
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in the US, DMD Therapeutics Inc. is a biotechnology firm, providing treatment for a genetic disease, Duchenne muscular dystrophy.
Current Investors
Ryan's Quest, Michael's Cause, Pietro's Fight
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceuticals
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
DMD Therapeutics Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.